OLIVIA JOHNSON: Open Payments
NPI 1649969460 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 55 payments from 23 companies in 2025. Trend: 2023 $61 · 2024 $662 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $128 |
| Novo Nordisk Inc | 4 | $122 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| UCB, Inc. | 4 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $98 |
| Viatris Specialty LLC | 4 | $87 |
| Exact Sciences Corporation | 3 | $70 |
| Smith+Nephew, Inc. | 2 | $69 |
| Boston Scientific Corporation | 3 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
Products named: REXULTI, VRAYLAR, FANAPT, Kerendia, YUPELRI, GRAFIX PL, Rybelsus, CDS broad portfolio offering.
Industry payments across CA — which companies pay providers there.
